E. A. Engels, Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients, JAMA, vol.306, issue.17, pp.1891-1901, 2011.
DOI : 10.1001/jama.2011.1592

C. M. Vajdic and M. T. Van-leeuwen, Cancer incidence and risk factors after solid organ transplantation, International Journal of Cancer, vol.74, issue.8, pp.1747-1754, 2009.
DOI : 10.1056/NEJM199012203232502

A. E. Grulich, M. T. Van-leeuwen, M. O. Falster, and C. M. Vajdic, Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis, The Lancet, vol.370, issue.9581, pp.59-67, 2007.
DOI : 10.1016/S0140-6736(07)61050-2

T. V. Ajithkumar, C. A. Parkinson, A. Butler, and H. M. Hatcher, Management of solid tumours in organ-transplant recipients, The Lancet Oncology, vol.8, issue.10, pp.921-932, 2007.
DOI : 10.1016/S1470-2045(07)70315-7

M. T. Oruc, A. Soran, A. K. Jain, J. W. Wilson, and J. Fung, De novo breast cancer in patients with liver transplantation: University of Pittsburgh's experience and review of the literature, Liver Transplantation, vol.20, issue.1
DOI : 10.1097/01.LAB.0000029150.90532.24

R. F. Saidi, P. S. Dudrick, and M. H. Goldman, Colorectal cancer after renal transplantation, Transplantation Proceedings, vol.35, issue.4, pp.1410-1412, 2003.
DOI : 10.1016/S0041-1345(03)00478-0

D. Collett, L. Mumford, N. R. Banner, J. Neuberger, and C. Watson, Comparison of the Incidence of Malignancy in Recipients of Different Types of Organ: A UK Registry Audit, American Journal of Transplantation, vol.3, issue.Suppl 2
DOI : 10.1002/9780470870709

I. R. Hardie, R. W. Strong, L. C. Hartley, P. W. Woodruff, and G. J. Clunie, Skin cancer in Caucasian renal allograft recipients living in a subtropical climate, pp.177-183, 1980.

J. Boyle, R. M. Mackie, J. D. Briggs, B. J. Junor, and T. C. Aitchison, Cancer, warts, and sunshine in renal transplant patients. A case-control study, Lancet Lond. Engl, vol.1, pp.702-705, 1984.
DOI : 10.1016/s0140-6736(84)92221-9

M. M. Hartevelt, J. N. Bavinck, A. M. Kootte, B. J. Vermeer, and J. P. Vandenbroucke, INCIDENCE OF SKIN CANCER AFTER RENAL TRANSPLANTATION IN THE NETHERLANDS, Transplantation, vol.49, issue.3
DOI : 10.1097/00007890-199003000-00006

B. Bavinck and J. N. , The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation61, pp.715-721, 1996.

H. M. Ramsay, A. A. Fryer, C. M. Hawley, A. G. Smith, and P. N. Harden, Non-melanoma skin cancer risk in the Queensland renal transplant population, British Journal of Dermatology, vol.36, issue.5, pp.950-956, 2002.
DOI : 10.1016/S0041-1345(00)02486-6

R. P. Dickson, R. D. Davis, J. B. Rea, and S. M. Palmer, High Frequency of Bronchogenic Carcinoma After Single-lung Transplantation, The Journal of Heart and Lung Transplantation, vol.25, issue.11, pp.1297-1301, 2006.
DOI : 10.1016/j.healun.2006.09.009

C. J. Hoffmann, A. K. Subramanian, A. M. Cameron, and E. A. Engels, Incidence and Risk Factors for Hepatocellular Carcinoma After Solid Organ Transplantation, Transplantation, vol.86, issue.6
DOI : 10.1097/TP.0b013e3181837761

B. Bavinck and J. N. , Keratotic Skin Lesions and Other Risk Factors Are Associated with Skin Cancer in Organ-Transplant Recipients: A Case???Control Study in The Netherlands, United Kingdom, Germany, France, and Italy, Journal of Investigative Dermatology, vol.127, issue.7, pp.1647-1656, 2007.
DOI : 10.1038/sj.jid.5700776

A. Vera, Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis, Transplantation, vol.75, issue.12, pp.1983-1988, 2003.
DOI : 10.1097/01.TP.0000058744.34965.38

A. Goh and A. Vathsala, Native Renal Cysts and Dialysis Duration Are Risk Factors for Renal Cell Carcinoma in Renal Transplant Recipients, American Journal of Transplantation, vol.67, issue.Suppl 2, pp.86-92, 2011.
DOI : 10.1097/00005792-199007000-00003

G. Heinz-peer, M. Schoder, T. Rand, G. Mayer, and G. H. Mostbeck, Prevalence of acquired cystic kidney disease and tumors in native kidneys of renal transplant recipients: a prospective US study., Radiology, vol.195, issue.3, pp.667-671, 1995.
DOI : 10.1148/radiology.195.3.7753991

C. M. Vajdic, Cancer Incidence Before and After Kidney Transplantation, JAMA, vol.296, issue.23, pp.2823-2831, 2006.
DOI : 10.1001/jama.296.23.2823

V. Mazzaferro, Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis, New England Journal of Medicine, vol.334, issue.11, pp.693-699, 1996.
DOI : 10.1056/NEJM199603143341104

W. Qunibi, Serologic association of human herpesvirus eight with posttransplant Kaposi's sarcoma in Saudi Arabia, pp.583-585, 1998.

M. Kauffman and H. , Transplant tumor registry: donor related malignancies, Transplantation, vol.74, issue.3, pp.358-362, 2002.
DOI : 10.1097/00007890-200208150-00011

A. K. Chui, Risk of tumor transmission in transplantation from donors with primary brain tumors: an Australian and New Zealand registry report, Transplantation Proceedings, vol.31, issue.1-2, pp.1266-1267, 1999.
DOI : 10.1016/S0041-1345(98)01989-7

A. Gutierrez-dalmau and J. M. Campistol, Immunosuppressive Therapy and Malignancy in Organ Transplant Recipients, Drugs, vol.120, issue.6, pp.1167-1198, 2007.
DOI : 10.3748/wjg.v11.i10.1420

C. Confavreux, Risk of cancer from azathioprine therapy in multiple sclerosis: A case-control study, Neurology, vol.46, issue.6, pp.1607-1612, 1996.
DOI : 10.1212/WNL.46.6.1607

J. Dantal, Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens, Lancet Lond

E. O. Kehinde, Triple therapy and incidence ofde novo cancer in renal transplant recipients, British Journal of Surgery, vol.50, issue.7, pp.985-986, 1994.
DOI : 10.1016/S0272-6386(87)80074-4

O. Donovan and P. , Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science309, pp.1871-1874, 2005.

I. Penn, Cancers in cyclosporine-treated vs azathioprine-treated patients, Transplant. Proc, vol.28, pp.876-878, 1996.

M. Hojo, Cyclosporine induces cancer progression by a cell-autonomous mechanism, pp.530-534, 1999.
DOI : 10.1097/00005392-199909010-00110

M. R. Karagas, Non-melanoma skin cancers and glucocorticoid therapy, British Journal of Cancer, vol.78, issue.5, pp.683-686, 2001.
DOI : 10.1054/bjoc.2001.1931

URL : http://www.nature.com/bjc/journal/v85/n5/pdf/6691931a.pdf

E. L. Yanik, Sirolimus Use and Cancer Incidence Among US Kidney Transplant Recipients, American Journal of Transplantation, vol.8, issue.1, pp.129-136, 2015.
DOI : 10.1111/j.1600-6143.2008.02430.x

URL : http://onlinelibrary.wiley.com/doi/10.1111/ajt.12969/pdf

K. Budde, Five-Year Outcomes in Kidney Transplant Patients Converted From Cyclosporine to Everolimus: The Randomized ZEUS Study, American Journal of Transplantation, vol.12, issue.1
DOI : 10.1111/j.1600-6143.2012.04159.x

M. S. Shiels, Cancer stage at diagnosis in patients infected with the human immunodeficiency virus and transplant recipients. Cancer121, pp.2063-2071, 2015.

C. A. Harwood, Clinicopathologic features of skin cancer in organ transplant recipients: A retrospective case-control series, Journal of the American Academy of Dermatology, vol.54, issue.2, pp.290-300, 2006.
DOI : 10.1016/j.jaad.2005.10.049

A. K. Gupta, C. J. Cardella, and H. Haberman, Cutaneous Malignant Neoplasms in Patients With Renal Transplants, Archives of Dermatology, vol.122, issue.11, pp.1288-1293, 1986.
DOI : 10.1001/archderm.1986.01660230080015

C. C. Otley, B. M. Coldiron, T. Stasko, and G. Goldman, Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants

G. Zavos, Incidence and Management of Kaposi Sarcoma in Renal Transplant Recipients: The Greek Experience, Transplantation Proceedings, vol.46, issue.9, pp.3199-3202, 2014.
DOI : 10.1016/j.transproceed.2014.09.165

A. Gutiérrez-dalmau, Efficacy of Conversion to Sirolimus in Posttransplantation Kaposi???s Sarcoma, Transplantation Proceedings, vol.37, issue.9, pp.3836-3838, 2005.
DOI : 10.1016/j.transproceed.2005.10.076

G. Stallone, Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients, New England Journal of Medicine, vol.352, issue.13
DOI : 10.1056/NEJMoa042831

J. F. Buell, De Novo Colorectal Cancer: Five-Year Survival is Markedly Lower in Transplant Recipients Compared With the General Population, Transplantation Proceedings, vol.37, issue.2, pp.960-961, 2005.
DOI : 10.1016/j.transproceed.2004.12.122

T. Grochowiecki, A matched case-control study on the prognosis of native kidney neoplasia in renal transplant recipients, Transplant International, vol.25, issue.9-10, pp.455-458, 2002.
DOI : 10.1097/00007890-200003150-00033

I. Penn, The effect of immunosuppression on pre-existing cancers. Transplantation55, pp.742-747, 1993.

I. Penn, Evaluation of transplant candidates with pre-existing malignancies, Ann. Transplant. Q. Pol. Transplant. Soc, vol.2, pp.14-17, 1997.

X. Tillou, Cancer de la prostate avant transplantation r??nale??: ??tude multicentrique, Progr??s en Urologie, vol.24, issue.13, p.853, 2014.
DOI : 10.1016/j.purol.2014.08.155

A. Kumar and D. T. Le, Hepatocellular Carcinoma Regression After Cessation of Immunosuppressive Therapy, Journal of Clinical Oncology, vol.34, issue.10, pp.90-92, 2016.
DOI : 10.1200/JCO.2013.51.4067

E. Thimonier, malignancies after liver transplantation for alcoholic liver disease, Clinical Transplantation, vol.16, issue.Suppl 1, pp.1339-1348, 2014.
DOI : 10.1111/j.1432-2277.2003.tb00287.x

C. L. Boils, D. N. Aljadir, and A. W. Cantafio, Use of the PD-1 Pathway Inhibitor Nivolumab in a Renal Transplant Patient With Malignancy, American Journal of Transplantation, vol.179, issue.8
DOI : 10.4049/jimmunol.179.8.5204

S. Euvrard, External anogenital lesions in organ transplant recipients. A clinicopathologic and virologic assessment, Archives of Dermatology, vol.133, issue.2, pp.175-178, 1997.
DOI : 10.1001/archderm.133.2.175

J. Adami, Cancer risk following organ transplantation: a nationwide cohort study in Sweden, British Journal of Cancer, vol.89, issue.7, pp.1221-1227, 2003.
DOI : 10.1038/sj.bjc.6601219